| N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm. | |
| | |
MedLine Citation:
|
PMID: 17403613 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIMS: To assess the value of plasma NT proBNP levels for predicting adverse outcomes in patients with dilated cardiomyopathy (DCM). METHODS: Seventy-eight patients with DCM (EF <40%) with sinus rhythm were enrolled. All patients had undergone echocardiographic examination, coronary angiography, and cardiac catheterisation. Blood samples for plasma NT proBNP levels were taken at rest following echocardiographic examination. Patients were followed up for 660+/-270 days for clinical endpoints defined as; death from worsening heart failure, sudden cardiac death and heart transplantation (Tx). RESULTS: Clinical end points were observed in 19 patients (5 Tx, 4 sudden cardiac death, 10 death from worsening heart failure). Variables associated with an increased hazard of clinical endpoints in univariate analysis were log NT proBNP, age, NYHA functional class, left ventricle ejection fraction, mitral valve effective regurgitation orifice area, and E wave deceleration time. The plasma level of NT proBNP (Hazard ratio=2.5 [95% CI: 1.3-4.7], p=0.0024) and age (hazard ratio=0.94 [95% CI: 0.90-0.98], p=0.0005) were the independent variables associated with an increased risk of clinical endpoints. NT proBNP plasma level >4500 pg/ml detected patients with clinical endpoints with a sensitivity, and specificity of 72%, 80%, respectively. The event free survival was found to be significantly lower in patients with NT proBNP levels >4500 pg/ml. CONCLUSION: NT proBNP seems to be a strong predictor of adverse outcomes in patients with DCM with sinus rhythm and may be used as a reliable biological marker in risk stratification. |
| | |
Authors:
|
Kursat Tigen; Tansu Karaahmet; Gokhan Kahveci; Ali Cevat Tanalp; Atilla Bitigen; Hakan Fotbolcu; Fatih Bayrak; Bulent Mutlu; Yelda Basaran |
Related Documents
:
|
19293713 - B-type natriuretic peptide: a strong predictor of early and late mortality in patients ... 11755863 - Increased endothelin-1 plasma levels in giant cell arteritis: a report on four patients. 7620953 - Lupus anticoagulant in patients with peripheral vascular disease: a prospective study. |
Publication Detail:
|
Type: Journal Article Date: 2007-04-02 |
Journal Detail:
|
Title: Heart, lung & circulation Volume: 16 ISSN: 1443-9506 ISO Abbreviation: Heart Lung Circ Publication Date: 2007 Aug |
Date Detail:
|
Created Date: 2007-07-09 Completed Date: 2007-10-09 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 100963739 Medline TA: Heart Lung Circ Country: Australia |
Other Details:
|
Languages: eng Pagination: 290-4 Citation Subset: IM |
Affiliation:
|
Kartal Kosuyolu Heart Education and Research Hospital, Department of Cardiology, Istanbul, Turkey. mktigen@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Analysis of Variance Biological Markers / blood Cardiomyopathy, Dilated / blood*, complications, diagnosis*, physiopathology Child Death, Sudden, Cardiac / etiology Echocardiography Female Follow-Up Studies Heart Conduction System / metabolism*, physiopathology*, ultrasonography Heart Failure / etiology, physiopathology Humans Male Middle Aged Natriuretic Peptide, Brain / blood* Peptide Fragments / blood* Prognosis Proportional Hazards Models Prospective Studies Research Design Sensitivity and Specificity Stroke Volume Survival Analysis Ventricular Dysfunction, Left / etiology, physiopathology |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Peptide Fragments; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: TRAIL signalling: decisions between life and death.
Next Document: Duration, combination and timing: the signal integration model of dendritic cell activation.